Our dedication to research has produced notable achievements benefiting the practice of obstetrics and gynecology with an impressive record of worldwide firsts. Our commitment to women's healthcare is ongoing, with support for professional organizations devoted to research and education in family planning, treatment of infertility, and hormone replacement.



Where we are today points to where we will be in the future: a major contributor to the practice of obstetrics and gynecology, dedicated to advancing the hormonal care of women - at every stage of their adult lives.

Contraception - our research includes alternative hormones and delivery systems, as well as a birth control vaccine.

Infertility - in 1997 we introduced our first genetically engineered fertility product and are continuing our research efforts in this area.

Hormone replacement therapy - research is concentrated on compounds for postmenopausal women.



Organon Inc.
W. Orange, N.J. 07052
 Innovators of Endocrine Products for Women


1998 ORGANON INC.
OR5C-333